Table S6 from Novel Thienoduocarmycin–Trastuzumab ADC Demonstrates Strong Antitumor Efficacy with Favorable Safety Profile in Preclinical Studies

Table (database) Safety profile
DOI: 10.1158/1535-7163.24710080.v1 Publication Date: 2023-12-01T07:53:07Z